title: Course of severe ulcerative colitis in northern India.
abstract: Thirty patients with severe ulcerative colitis were studied prospectively. Sixty percent (18/30) of severe ulcerative colitis were in remission after mean duration of 9.2 days (range 2-20 days) of intensive intravenous therapy without major side effects of steroids. Factors predicting poor response to medical therapy on admission are: stool frequency > or = 9 per day, pulse rate > or = 120/minute, temperature > or = 38 degrees C, Albumin < or = 2 gm, mucosal tags on plain x-ray abdomen and pancolitis.
authors.affiliation: Department of Gastroenterology, G.B. Pant Hospital, New Delhi.
authors.forename: R
authors.initials: R
authors.lastname: Gulati
authors.forename: K K
authors.initials: KK
authors.lastname: Rawal
authors.forename: N
authors.initials: N
authors.lastname: Kumar
authors.forename: M
authors.initials: M
authors.lastname: Jain
authors.forename: A S
authors.initials: AS
authors.lastname: Puri
authors.forename: A
authors.initials: A
authors.lastname: Govil
authors.forename: A K
authors.initials: AK
authors.lastname: Sachdeva
authors.forename: A
authors.initials: A
authors.lastname: Chaudhary
mesh_terms: D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000188:drug therapy; D003906:Developing Countries; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007194:India; D007262:Infusions, Intravenous; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008875:Middle Aged; D012008:Recurrence; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D008795:Metronidazole; D000667:Ampicillin; D006854:Hydrocortisone